Merger and Acquisition
AT4 secures 20% Kilba tungsten offtake right and subscribes for Mammoth Minerals shares
Headline consideration
A$1,577,333
60,666,666 Mammoth shares at A$0.026 per share
Interest acquired
Approximately 8.6% of Mammoth
On completion of both tranches and Mammoth’s broader placement
Mineral resource
7.2Mt at 0.19% WO₃
13,800t contained WO₃, JORC 2012, as reported by Mammoth
Summary
American Tungsten & Antimony Ltd (ASX: AT4) has signed a Binding Framework Agreement with Mammoth Minerals Limited (ASX: M79) covering a strategic investment, an exclusive tungsten offtake right and a joint work program. AT4 will subscribe for a total of 60,666,666 fully paid ordinary shares in Mammoth at A$0.026 per share, a total of A$1,577,333. Mammoth has granted AT4 the exclusive right to purchase 20% of all tungsten concentrate and other tungsten-bearing product produced from within the current Kilba Mineral Resource in Western Australia, to be processed into ammonium paratungstate (APT) at AT4’s Del Sol Refinery in Nevada. The company states the right is to be documented in a binding Offtake Agreement, and that AT4 is not obliged to enter into it.
Consideration
| Component | Terms |
|---|---|
| Share subscription | 60,666,666 fully paid ordinary Mammoth shares at A$0.026 per share, total A$1,577,333 |
| Tranche 1 | 40,000,000 shares at A$0.026 (A$1,040,000), issued under Mammoth’s Listing Rule 7.1 placement capacity |
| Tranche 2 | 20,666,666 shares at A$0.026 (A$537,333), subject to Mammoth shareholder approval |
| Shareholding | Approximately 8.6% of Mammoth on completion of both tranches and Mammoth’s broader placement, before the issue of Kilba acquisition consideration shares |
| Shareholding limit | AT4 will not move to 10% or more of Mammoth before the Offtake Agreement is signed and any Mammoth shareholder approval required under Listing Rule 10.1 is obtained |
| Use of funds | Due diligence on Kilba and the cash consideration for the Kilba acquisition, with not less than 70% applied to Kilba |
| Funding | The investment will be funded from AT4’s existing cash reserves |
| Offtake right | Exclusive right to purchase 20% of all tungsten concentrate and other tungsten-bearing product from the current Kilba Mineral Resource, measured by contained WO₃, until depleted; extension to future Mineral Resources by agreement |
| Pricing principles | To be negotiated; APT-linked concentrate pricing, with payability and penalties in line with industry practice; refining margin retained by AT4 |
| Offtake Agreement | To be negotiated in good faith, targeting signing within 3 months after the Investigation Report is approved; AT4 may require signing within 40 business days, with terms not agreed determined by an independent expert |
| Step-in right | If the Kilba acquisition agreement terminates or does not complete in time, AT4 may require Mammoth to transfer M79 WA Pty Ltd, or assign its rights under the acquisition agreement, to AT4 for the amounts paid by M79 WA Pty Ltd under that agreement |
| Costs | Each party bears its own costs; Mammoth funds bulk sampling and beneficiation testwork; AT4 funds hydrometallurgical testwork at Del Sol and the extension of its APT concept study |
| Termination | The offtake right lapses if no Offtake Agreement is signed within 18 months, unless AT4 has called for the Offtake Agreement; the placement funds are not refundable on termination |
| Liability caps | Mammoth’s liability capped at A$1.3 million and AT4’s at A$0.5 million, excluding the subscription amount |
Conditions
- Tranche 1 is conditional on the Agreement being signed and Mammoth’s announcement of the transaction
- Tranche 2 is subject to Mammoth shareholder approval at a general meeting to be held within 3 months, and to the Agreement and the Kilba acquisition agreement remaining on foot
- Implementation of the offtake is subject to AT4 being satisfied with its due diligence
- Implementation of the offtake is subject to the Kilba tenure being granted and remaining in good standing
- Implementation of the offtake is subject to negotiation and signing of the Offtake Agreement
- Implementation of the offtake is subject to any required shareholder and regulatory approvals and other customary conditions
Timetable
| 22 April 2027 | Mammoth must use best endeavours to complete the Kilba acquisition by this date |
|---|
Project snapshot
| Item | Detail |
|---|---|
| Mineral Resource (total) | 7.2Mt at 0.19% WO₃ for 13,800t of contained WO₃, JORC 2012, at a 0.05% WO₃ cut-off, as reported by Mammoth in its ASX announcement dated 16 November 2026 |
| Indicated | 5,700 at 0.20% WO₃ for 11,600 contained WO₃ (t); 79% Indicated by tonnage |
| Inferred | 1,460 at 0.15% WO₃ for 2,200 contained WO₃ (t) |
Source: American Tungsten & Antimony announcement dated 16 November 2026. This page summarises information from the company's public announcement and is provided for general information only. It is not financial product advice, a recommendation or an offer, and it does not take into account any person's objectives, financial situation or needs. Figures and terms are taken from the announcement and may be incomplete or may have changed since publication. Refer to the original announcement for full details. Kamoa Capital has not independently verified the information.
More from American Tungsten & Antimony
Latest mining M&A deals
- Asara Resources signs binding term sheet to acquire Siguiri Gold Corp., holder of Guinea gold permits
- Patagonia Gold to acquire Cognito Limited (Don Sixto gold project) from Pan American Silver subsidiaries
- Teako Minerals to contribute 90% of eight Norwegian silver projects to DS Deutsche Silber AG
- Wayfinder Metals proposes to earn up to 85% of Mirasol’s La Curva and Libanesa gold-silver projects
- Corazon Mining signs binding HOA for staged sale of Mt Gilmore Tenement (EL 8379) to Raiju Resources
- Bayridge Resources to acquire remaining 49% of 1461433 B.C. Ltd., owner of Baker Lake Uranium Project
